Amicus Therapeutics, Inc. Pulls $86M IPO Citing Market Conditions

Amicus Therapeutics Inc. has withdrawn its initial public offering amid difficult market conditions, the latest in a spate of biopharmaceutical companies to do so.

>>> Discuss This Story

MORE ON THIS TOPIC